瑞科生物拟参与H股全流通计划并计划变更经营范围

财中社
21 May

5月21日,瑞科生物-B(02179)发布公告,宣布公司拟参与H股全流通计划,计划将1.42亿股未上市股份转为H股。截至2025年5月21日,公司总股本为4.83亿股,其中H股总数为3.16亿股,占总股本比例为65.46%;未上市股份总数为1.67亿股,占总股本比例为34.54%。此次H股全流通申请意向股数占未上市股份比例为85.09%,占公司总股本比例为29.39%。完成后,H股总数将变更为...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10